NEW YORK (GenomeWeb) – Interpace Diagnostics today announced that it received notification from the Nasdaq on Wednesday that it has regained compliance with a listing requirement calling for a minimum closing bid price on the company's stock of at least $1 per share.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.